Patents by Inventor Piotr P. Ruchala

Piotr P. Ruchala has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified mini-hepcidin peptides and methods of using thereof
    Patent number: 9328140
    Abstract: Disclosed herein are peptides which exhibit hepcidin activity and methods of making and using thereof.
    Type: Grant
    Filed: December 6, 2012
    Date of Patent: May 3, 2016
    Assignee: The Regents of the University of California
    Inventors: Tomas Ganz, Elizabeta Nemeth, Piotr P. Ruchala
  • Modified Mini-Hepcidin Peptides and Methods of Using Thereof
    Publication number: 20140336110
    Abstract: Disclosed herein are peptides which exhibit hepcidin activity and methods of making and using thereof.
    Type: Application
    Filed: December 6, 2012
    Publication date: November 13, 2014
    Applicant: The Regents of the University of California
    Inventors: Tomas Ganz, Elizabeta Nemeth, Piotr P. Ruchala
  • Azuvirin peptides
    Patent number: 8716246
    Abstract: Azuvirin peptides are small peptide agents useful in delivering functional moieties, such as sensitizers, chemotherapeutic agents and the like to cancer cells expressing ephrin receptors. The peptides are also useful for administration to a patient suffering from a viral infection, or to an individual facing exposure to a viral infection, especially one caused by the Human Immunodeficiency Virus (HIV-1).
    Type: Grant
    Filed: January 3, 2012
    Date of Patent: May 6, 2014
    Assignee: The Regents of the University of California
    Inventors: Piotr P. Ruchala, Robert I. Lehrer
  • Azuvirin Peptides
    Publication number: 20130029903
    Abstract: Azuvirin peptides are small peptide agents useful in delivering functional moieties, such as sensitizers, chemotherapeutic agents and the like to cancer cells expressing ephrin receptors. The peptides are also useful for administration to a patient suffering from a viral infection, or to an individual facing exposure to a viral infection, especially one caused by the HIV-1 retrovirus.
    Type: Application
    Filed: January 3, 2012
    Publication date: January 31, 2013
    Inventors: Piotr P. Ruchala, Robert I. Lehrer